Cindy Pau

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Activity Monitor Intervention to Promote Physical Activity of Physicians-In-Training: Randomized Controlled Trial

Anne N. Thorndike, Sarah Mills, Lillian Sonnenberg et al. · PLoS ONE · 2014 · 75 citations · Full text

Medicine, Health Behavior, Exercise Prescription +14

Identification of subjects with polycystic ovary syndrome using electronic health records

Víctor M. Castro, Yuanyuan Shen, Sheng Yu et al. · Reproductive Biology and Endocrinology · 2015 · 52 citations · Full text

Medicine, Endocrinology, Gynecology +16

Phenotype and Tissue Expression as a Function of Genetic Risk in Polycystic Ovary Syndrome

Cindy Pau, Tim Mosbruger, Richa Saxena et al. · PLoS ONE · 2017 · 52 citations · Full text

Medicine, Endocrinology, Genetics +17